1 Cholesterol-CHD connection: evidence for the benefit of lipoprotein modification --; Epidemiological Studies on Atherosclerosis and Coronary Heart Disease --; Genetics of Coronary Heart Disease and Atherosclerosis: Clinical and Epidemiological Implications --; The Vegetative Nervous System and Cardiovascular Disease --; Nosology of Hyperlipoproteinemias --; Nutrition: Population Studies --; Nutrition: Special Diets and Metabolic Effects of Fats and Proteins --; Athersclerosis, Computer Handling Studies and Mathematical Modelling --; New Perspectives in the Treatment of Hypercholesterolemia and the Prevention of Atherosclerosis --; LDL Apheresis: Efficacy Versus Ethical and Social Aspects --; Developments in Lipoprotein and Apoprotein Research --; Thrombosis and Atherosclerosis: Clinical Insights --; Glycosaminoglycans and their Clinical Implications --; Calcium Antagonists and Atherosclerosis --; Atherosclerosis Regression from a Clinical and Anatomo-Pathological Standpoint --; Atherosclerosis in Youth --; New Lipid Lowering Agents --; LDL Apheresis --; Standardization of Apoprotein Measurement in Blood --; Cardiologists and CHD and Atherosclerosis Prevention Versus Therapy --; Rationale for Prevention in High Risk Subjects --; Hyperlipoproteinemia Therapy: When to Opt for Drug Combinations --; Hypertension as a Risk Factor --; Invasive Therapy of Coronary and Cerebrovascular Diseases.